tiprankstipranks
Puma Biotechnology (PBYI)
NASDAQ:PBYI

Puma Biotechnology (PBYI) Stock Investors

582 Followers
Based on 747,525 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold PBYI
On average, investors allocate 0.00% of their portfolios to PBYI
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 747,525 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding PBYI

3.8%
Last 7
Days
10.7%
Last 30
Days
Percentages indicate the change in the number of portfolios holding PBYI, out of 747,525 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

PBYI Investor Activity

Action
Any
Any
Investor Performance
Any
Any
No data currently available
Based on the activity of 14,195 investors who made their portfolios public
The table shows changes in PBYI in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

PBYI Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Bristol-Myers Squibb
3.23%
-0.90%
+1.52%
86.44B
Healthcare
ServiceNow
3.85%
-1.30%
-0.20%
154.00B
Technology
Trade Desk
4.65%
-1.43%
-0.18%
46.96B
Technology
Baidu
5.24%
-0.12%
+11.69%
32.76B
Communication Services
GE Aerospace
5.19%
-0.16%
+1.03%
174.18B
Industrials
Merck & Company
3.86%
-0.51%
+3.45%
318.55B
Healthcare
Caterpillar
4.41%
+1.02%
+1.66%
170.01B
Industrials
Cisco Systems
4.26%
-1.06%
+0.22%
190.64B
Technology
Devon Energy
5.33%
-1.30%
+3.61%
29.96B
Energy
Qualcomm
4.81%
-0.35%
+4.27%
207.81B
Technology
Based on the activity of 747,525 active portfolios
Open your Smart Portfolio

PBYI Investor Analysis

PBYI investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
7.1%
of PBYI holders
are under 35
Average Segment Performance
Average P/E Ratio20.77
Beta7.15
Dividend Yield6.79%
PBYI investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
40.5%
of PBYI holders
are between 35–55
Average Segment Performance
Average P/E Ratio19.59
Beta11.22
Dividend Yield6.44%
PBYI investors over 55

Over 55

3.2%
Last 30 days
Holdings Change
52.4%
of PBYI holders
are over 55
Average Segment Performance
Average P/E Ratio19.41
Beta3.84
Dividend Yield7.80%
Overview of age group and performance of PBYI stock investors
See who invests in PBYI according to age group and performance.

FAQ

How many retail Investors hold PBYI?
<0.1% of TipRanks' retail investors hold PBYI in their portfolios.
    What is PBYI Investor Sentiment?
    PBYI’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of PBYI in the last 7 days?
      ▼ 3.8% of TipRanks' retail investors changed their holding of PBYI in the last 7 days.
        What percentage of retail investors changed their holding of PBYI in the last 30 days?
        ▼ 10.7% of TipRanks' retail investors changed their holding of PBYI in the last 30 days.
          What is the average age of retail investors who hold PBYI?
          The average age of PBYI Holders is over 55.
            What other stocks have PBYI investors also bought?
            PBYI Investors also bought BMY, NOW, TTD, BIDU, GE, MRK, CAT, CSCO, DVN, QCOM.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ALNYAlnylam Pharma
              BCRXBioCryst
              CYTKCytokinetics
              EWEdwards Lifesciences
              AVDLAvadel Pharmaceuticals
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis